Lipase News and Research

RSS
Study identifies FGF21 protein as potential therapeutic agent for cardiovascular diseases, type 2 diabetes

Study identifies FGF21 protein as potential therapeutic agent for cardiovascular diseases, type 2 diabetes

Vanderbilt study offers a glimmer of hope to alcoholics suffering from depression

Vanderbilt study offers a glimmer of hope to alcoholics suffering from depression

TSRI scientists discover molecular ‘switch’ that could reduce nicotine addiction

TSRI scientists discover molecular ‘switch’ that could reduce nicotine addiction

UF researchers reveal link between chronic stress and fat metabolism

UF researchers reveal link between chronic stress and fat metabolism

Cholesterol essential for health, but also plays key role in longevity

Cholesterol essential for health, but also plays key role in longevity

Kanuma approved as first treatment for patients with LAL deficiency

Kanuma approved as first treatment for patients with LAL deficiency

Ingenza and Imperial researchers work together to improve nasogastric feeding tube placement

Ingenza and Imperial researchers work together to improve nasogastric feeding tube placement

New trial results show efficacy of novel enzyme-replacement therapy for genetic lipid disorder

New trial results show efficacy of novel enzyme-replacement therapy for genetic lipid disorder

Vascular side effects prevent first-line ponatinib use in chronic phase CML

Vascular side effects prevent first-line ponatinib use in chronic phase CML

Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

Abide Therapeutics begins Phase 1a study of ABX-1431 investigational endocannabinoid system modulator

Abide Therapeutics begins Phase 1a study of ABX-1431 investigational endocannabinoid system modulator

Nutrition experts offer tips to employees working in sedentary environment

Nutrition experts offer tips to employees working in sedentary environment

MedImmune, AstraZeneca present encouraging results from new combination-focused immuno-oncology portfolio at ASCO 2015

MedImmune, AstraZeneca present encouraging results from new combination-focused immuno-oncology portfolio at ASCO 2015

Combination of nivolumab and ipilimumab drugs can improve outcomes in patients with advanced melanoma

Combination of nivolumab and ipilimumab drugs can improve outcomes in patients with advanced melanoma

Study: Alginate-enriched bread can reduce fat digestion, circulatory lipids in NAFLD patients

Study: Alginate-enriched bread can reduce fat digestion, circulatory lipids in NAFLD patients

Synageva announces submission of Kanuma application to Cofepris for treatment of LAL Deficiency

Synageva announces submission of Kanuma application to Cofepris for treatment of LAL Deficiency

FDA approves CHOLBAM (cholic acid) for treatment of bile acid synthesis disorders

FDA approves CHOLBAM (cholic acid) for treatment of bile acid synthesis disorders

Abide, Oxford partner to explore therapeutic potential of serine hydrolases

Abide, Oxford partner to explore therapeutic potential of serine hydrolases

Study on digestion of milk could lead to development of new formulas for premature babies

Study on digestion of milk could lead to development of new formulas for premature babies

Medison to market uniQure's Glybera in Israel for treatment of lipoprotein lipase deficiency

Medison to market uniQure's Glybera in Israel for treatment of lipoprotein lipase deficiency